Form 4 for PFE Pfizer
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001225208-23-002814 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-24 | 2023-02-22 | PFE | LANKLER DOUGLAS M | EVP | F - Tax | $42.38 | -19.9K | 161.5K | -11% | -$842.4K |
| DM | 2023-02-24 | 2023-02-23 | PFE | LANKLER DOUGLAS M | EVP | A - Grant | $0.00 | +150.3K | 69.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | F | D | 19,878 | $42.38 | 161,535 | D | — | — | (F1) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). |
| 2 | Derivative | Stock Appreciation Rights | 2023-02-23 | A | A | 80,360 | $0.00 | 80,360 | D | $42.30 · 2028-02-23 to 2028-02-23 | 80,360 Common Stock | (F2) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
| 3 | Derivative | Stock Appreciation Rights | 2023-02-23 | A | A | 69,938 | $0.00 | 69,938 | D | $42.30 · 2030-02-23 to 2030-02-23 | 69,938 Common Stock | (F3) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |